SCHEMBL5020570

SCHEMBL5020570

CCCCc1oc2ccc(O)cc2c1C(=O)c1ccc(O)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EYA3 Q99504 5/20 0.77
PTPN1 P18031 1/20 0.77
SLC22A12 Q96S37 6/20 0.76
CYP2C9 P11712 2/20 0.57
TTR P02766 1/20 0.57
NR1H4 Q96RI1 1/20 0.53
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
ESR1 P03372 1/20 0.50
PGR P06401 1/20 0.50
CHRM2 P08172 1/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CHRM1 P11229 1/20 0.50
DRD1 P21728 1/20 0.50
TBXA2R P21731 1/20 0.50
SLC6A2 P23975 1/20 0.50
PDE4A P27815 1/20 0.50
SLC6A4 P31645 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14552011 0.91 EYA3 (0.72) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL5226741 0.91 EYA3 (0.72) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL5020569 0.91 SLC22A12 (0.68) EYA3PTPN1SLC22A12CYP2C9NR1H4
SCHEMBL4567255 0.90 EYA3 (0.70) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL11817673 0.90 EYA3 (0.70) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL5224414 0.89 EYA3 (0.69) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL5671722 0.88 EYA3 (0.67) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL28162857 0.88 EYA3 (0.67) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL6140040 0.88 EYA3 (0.67) EYA3PTPN1SLC22A12CYP2C9TTR
SCHEMBL5227159 0.87 EYA3 (0.66) EYA3PTPN1SLC22A12CYP2C9TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012062918-A1 PROCESS FOR THE PREPARATION OF 3-AROYL-5-AMINOBENZOFURAN DERIVATIVES LEK PHARMACEUTICALS D.D. (SI) 2012-05-18 WO disclosed